In vivo homing and differentiation characteristics of mature (CD45−) and immature (CD45+) 5T multiple myeloma cells

Experimental Hematology

Volumn 29, Issue 1, 2001, Pages 77-84

  Asosingh, Kewal ^a   De Raeve, Hendrik ^b   Croucher, Peter ^c   Goes, Eva ^a   Van Riet, Ivan ^a   Van Camp, Ben ^a   Vanderkerken, Karin ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Bone marrow; CD45; Homing; Myeloma

Indexed keywords

CD45 ANTIGEN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE ATROPHY; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; FLOW CYTOMETRY; LABELING INDEX; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD45; ANTIGENS, NEOPLASM; BONE MARROW; CELL DIFFERENTIATION; CELL DIVISION; CELL MOVEMENT; CELL SEPARATION; DNA REPLICATION; DNA, NEOPLASM; FLOW CYTOMETRY; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MULTIPLE MYELOMA; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OSTEOLYSIS; PARAPROTEINS; RECEPTOR, IGF TYPE 1; TUMOR STEM CELLS;

MURINAE;

EID: 0035164061     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00625-1     Document Type: Article

References (29)

1. Multiple myeloma; increasing evidence for a multistep transformation process
2. Evidence that multiple myeloma immunoglobulin heavy chain VDJ genes contain somatic mutations but show no intraclonal variations
3. Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse
4. Homing behaviour of the malignant cell clone in multiple myeloma
5. Human T cell subsets
6. Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event
7. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production
8. Unidirectional phenotypic changes within the T200 complex during activation of T cells
9. Transitions from high to low molecular weight isoforms of CD45 involve rapid activation of alternate mRNA splicing and slow turnover of surface CD45R
10. Transition in CD45 isoform expression during differentiation of normal and abnormal B cells
11. Human lymphocyte differentiation antigens HB-10 and HB-11.I. Ontogeny of antigen expression
12. Flow cytometric analysis of human bone marrow IV. Differential expression of T-200 common leukocyte antigen during normal hemopoiesis
13. Interleukin-6 gene expression in multiple myeloma; a characteristic of immature tumor cells
14. The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis
15. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen
16. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal
17. Animal model of human disease; multiple myeloma
18. Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice
19. Follow-up of bone lesions in an experimental multiple myeloma mouse model; description of an in vivo technique using radiography dedicated for mammography
20. Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse
21. The 5T2 mouse multiple myeloma model; characterization of 5T2 cells within the bone marrow
22. A model of multiple myeloma; culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse
23. Insulin like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells
24. In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells
25. Lymphocyte homing and homeostasis
26. Presence of hematopoietic stem cells in the adult liver
27. The proliferation potential of myeloma plasma cells manifest in the SCID-hu host
28. Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6
29. + subpopulations that can proliferate in response to IL-6 in human myelomas